Evidence map›Paper›PMID 42405346›Full record

ArticleJAC-antimicrobial resistance2026

Antimicrobial resistance among people with intellectual disabilities in long-term care facilities: an exploratory, isolate-based surveillance study based on routine diagnostics between 2018 and 2023 in the Netherlands.

Soemeja Hidad, Wieke Altorf-Van Der Kuil, Freek De Haan, Geraline Leusink, Aura Timen, Annelot F Schoffelen, Sabine C De Greeff, Infectious Diseases Surveillance Information System-Antimicrobial Resistance (ISIS-AR) study group, Infectious Diseases Surveillance Information System-Antimicrobial Resistance (ISIS-AR) study group

Abstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Soemeja HidadCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Wieke Altorf-Van Der KuilCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Freek De HaanCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Geraline LeusinkDepartment of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands.
Aura TimenDepartment of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands.
Annelot F SchoffelenCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Sabine C De GreeffCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Infectious Diseases Surveillance Information System-Antimicrobial Resistance (ISIS-AR) study group
Infectious Diseases Surveillance Information System-Antimicrobial Resistance (ISIS-AR) study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Little is known about the presence of resistant micro-organisms in people with intellectual disabilities (ID) residing in long-term care facilities (LTCFs). We explored the resistant percentages of six highly resistant micro-organisms (HRMOs) among people with ID in ID-LTCFs: ESBL-producing Methods: We included data on the first isolate per species, per patient, per year ordered by ID physicians, as delivered by 11 clinical microbiology laboratories, participating in the Dutch National Infectious Diseases Surveillance Information System-Antimicrobial Resistance (ISIS-AR) between 2018 and 2023. Resistance was classified based on phenotypic and genotypic test results. The resistance percentage for each HRMO was calculated as the percentage of resistant isolates among the total number of isolates for each corresponding species. Results: The percentage of resistant ESBL-E isolates among Conclusions: The resistance percentages for six HRMOs among positive diagnostic isolates ordered by ID physicians for people with ID in the Netherlands are low. The majority of HRMOs detected were isolated from older adults with ID. To estimate the burden of AMR and associated risk factors in the whole ID population, more extensive studies, including data from other medical specialties serving people with ID, such as general practitioners, are needed.

Identifiers

PMID42405346
PMCPMC13332802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.